中间α-球蛋白抑制因子H4(ITIH4)多克隆抗体(生物素标记)
Biotin-Linked Polyclonal Antibody to Inter Alpha-Globulin Inhibitor H4 (ITIH4)
IHRP; PK120; H4P; ITIHL1; Plasma Kallikrein-Sensitive Glycoprotein; Plasma kallikrein sensitive glycoprotein 120; Inter-alpha-trypsin inhibitor family heavy chain-related protein
- 编号LAH776Hu71
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源抗体标记
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物生物素
- 原抗体 -
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 695 ¥ 1621 ¥ 2316 ¥ 5790 ¥ 23160
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对ITIH4的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别ITIH4。
用法
免疫印迹:0.2-2µg/mL;1:250-2500
免疫组织化学:5-20µg/mL;1:25-100
免疫细胞化学:5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APH776Hu01 | 中间α-球蛋白抑制因子H4(ITIH4)活性蛋白 | Cell culture; Activity Assays. |
APH776Hu03 | 中间α-球蛋白抑制因子H4(ITIH4)活性蛋白 | Cell culture; Activity Assays. |
RPH776Hu02 | 中间α-球蛋白抑制因子H4(ITIH4)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPH776Hu03 | 中间α-球蛋白抑制因子H4(ITIH4)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPH776Hu01 | 中间α-球蛋白抑制因子H4(ITIH4)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAH776Hu03 | 中间α-球蛋白抑制因子H4(ITIH4)多克隆抗体 | WB; IHC; ICC; IP. |
PAH776Hu02 | 中间α-球蛋白抑制因子H4(ITIH4)多克隆抗体 | WB; IHC; ICC; IP. |
PAH776Hu01 | 中间α-球蛋白抑制因子H4(ITIH4)多克隆抗体 | WB; IHC; ICC; IP. |
LAH776Hu71 | 中间α-球蛋白抑制因子H4(ITIH4)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAH776Hu21 | 中间α-球蛋白抑制因子H4(ITIH4)单克隆抗体 | WB; IHC; ICC; IP. |
SEH776Hu | 中间α-球蛋白抑制因子H4(ITIH4)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMH776Hu | 中间α-球蛋白抑制因子H4(ITIH4)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
KSH776Hu01 | 中间α-球蛋白抑制因子H4(ITIH4)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Toxicology Letters | Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. [Pubmed: 23830989] |
International Journal of Medical Microbiology | Proteomic demonstration of the recurrent presence of inter-alpha-inhibitor H4 heavy-chain during aspergillosis induced in an animal model [Pubmed:24360996] |
Cancer Research and Treatment | Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma [pubmed:28724284] |
Diagnostics | Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J [Pubmed: 32585848] |
Liver Cancer | Biomarkers for locally advanced hepatocellular carcinoma patients treated with liver-directed combined radiotherapy [] |
留言咨询